APA (7th ed.) Citation

Davarci, G., Wängler, C., Eberhardt, K., Tulessin, M., Geppert, C., Schirrmacher, R., . . . Wängler, B. (2025). Preclinical Evaluation of Stable Integrin α v β 3 -Specific [ 198 Au]Gold Nanoparticles for Tumor Therapy. Pharmaceuticals (14248247), 18(11), 1670. https://doi.org/10.3390/ph18111670

Chicago Style (17th ed.) Citation

Davarci, Güllü, et al. "Preclinical Evaluation of Stable Integrin α V β 3 -Specific [ 198 Au]Gold Nanoparticles for Tumor Therapy." Pharmaceuticals (14248247) 18, no. 11 (2025): 1670. https://doi.org/10.3390/ph18111670.

MLA (9th ed.) Citation

Davarci, Güllü, et al. "Preclinical Evaluation of Stable Integrin α V β 3 -Specific [ 198 Au]Gold Nanoparticles for Tumor Therapy." Pharmaceuticals (14248247), vol. 18, no. 11, 2025, p. 1670, https://doi.org/10.3390/ph18111670.